
Dr. Anna Kirtava, MD, PhD: The Bridger Redefining Healthcare Innovation | The Pulse Magazine
Dr. Anna Kirtava, MD, PhD: The Bridger Redefining Healthcare Innovation, AI Governance & Global Health Equity
The Pulse Magazine
The Archive
Journeys, strategies and ideas from the people redefining business, leadership and innovation.

Dr. Anna Kirtava, MD, PhD: The Bridger Redefining Healthcare Innovation, AI Governance & Global Health Equity

Discover how Ben Moorey, Founder & CEO of Businessing.lol, is disrupting modern entrepreneurship with low-code development, Vibe-Based ROI, and a philosophy that turns business into a verb

In a world drowning in data, Carl D. Hays III is building something rarer than innovation certainty. Explore how this AI Founder and Doctoral Candidate is reshaping leadership across agriculture, construction, and energy by prioritizing trust, adoption, and human judgment over hype.

Explore Camille Bradbury’s journey and how HRinsidr is reshaping HR with practical tools, empathy-led leadership, AI-ready strategy, and compliance clarity.

Discover how Dr. Tiffany Nguyen-Ngo, Co-Owner & CEO of ARCpoint Labs Oklahoma City, is transforming healthcare through people-first leadership, operational innovation, and health equity advocacy. Featured in The Pulse Magazine 2026.

The powerful story of how Joan Peckolick founded Self Chec – a behavioral movement saving lives through early detection and preventive healthcare.

Our health system needs first aid stat! The medical profession is in dire need of a shot in the arm. If Humpty Dumpty sat on a wall today and took a great fall, forget the king’s horses and men. Better slap on a Band-Aid and call it a day. Need a pill? Over the hill.

A bombshell Cochrane review questions the effectiveness of anti-amyloid Alzheimer’s drugs like Leqembi and Kisunla, calling their benefits “absent or trivial” despite FDA approvals. Cochrane Analysis: Little to No Clinical Benefit The nonprofit Cochrane compiled data from 17 placebo-controlled studies on seven amyloid-beta-targeting monoclonal antibodies, involving over 20,000 people with mild cognitive impairment or mild Alzheimer’s dementia.

Reed Hastings, the legendary co-founder and longtime chair of Netflix, is stepping down from the board in June 2026. This news comes as Netflix reports strong Q1 earnings and moves on from its failed $72 billion Warner Bros Discovery acquisition. Netflix Confirms No Disagreements in Reed Hastings Departure In an SEC filing and shareholder letter

A powerful exploration of Chow Song Chee’s leadership journey, focusing on people, culture, and building inclusive, high-performance organizations.

A powerful exploration of Pamela Lebogang Motsoatsoe’s journey into emotional wellness, healing, and self-discovery revealing the path to inner strength and transformation.

A deep exploration of Jodi Orgill Brown’s leadership philosophy, highlighting resilience, human connection, and communication as the foundation of modern leadership.